Evidence map›Paper›PMID 39311782›Full record

ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2024

Seminoma characterized by thickening of the pituitary stalk

Bing Peng, Xingtian Wang, Yuhuan Deng, Yu Lian, Yanling Zheng, Jianren Kuang, Jinyu Qian, Jie Liang, Yanlin Zhang

Abstract readCase Reports
In one paragraph

Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bing PengDepartment of Endocrinology, First Affiliated Hospital of Army Medical University, Chongqing 400038. 1239739633@qq.com.
Xingtian WangDepartment of Radiology, First Affiliated Hospital of Army Medical University, Chongqing 400038.
Yuhuan DengDepartment of Endocrinology, First Affiliated Hospital of Army Medical University, Chongqing 400038.
Yu LianDepartment of Endocrinology, 958th Hospital of the Chinese People's Liberation Army, Chongqing 400020.
Yanling ZhengDepartment of Endocrinology, First Affiliated Hospital of Army Medical University, Chongqing 400038.
Jianren KuangDepartment of Endocrinology, First Affiliated Hospital of Army Medical University, Chongqing 400038.
Jinyu QianDepartment of Neurosurgery, First Affiliated Hospital of Army Medical University, Chongqing 400038, China.
Jie LiangDepartment of Endocrinology, First Affiliated Hospital of Army Medical University, Chongqing 400038.
Yanlin ZhangDepartment of Endocrinology, First Affiliated Hospital of Army Medical University, Chongqing 400038. 306294122@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intracranial seminoma is a rare malignant tumor originating from the germ cells, usually occurring in the pineal gland or pituitary gland. In June 2020, the Department of Endocrinology at the First Affiliated Hospital of Army Military Medical University admitted a 20-year-old male patient with an intracranial germ cell tumor and spinal metastases. The patient presented with headache, dizziness, and visual impairment. Enhanced magnetic resonance imaging (MRI) of the head indicated thickening of the pituitary stalk. After multidisciplinary consultation, the patient underwent endonasal transsphenoidal resection of the tumor, with the pathological diagnosis confirming germ cell tumor. The patient received regular radiotherapy postoperatively. One year later, the tumor recurred and metastasized, leading to a second surgery for tumor resection in the thoracic spinal canal, followed by continued chemotherapy. The patient's clinical symptoms, such as headache and visual disturbances, improved, but he continued to experience panhypopituitarism and required long-term hormone replacement therapy. Early diagnosis of intracranial germ cell tumors is challenging, and they are prone to metastasis and highly sensitive to radiotherapy and chemotherapy. Early diagnosis and multidisciplinary comprehensive treatment can help improve the quality of life and prognosis for patients.

Indexed as

Magnetic Resonance ImagingSeminomaBrain NeoplasmsHumansHypopituitarismMaleNeoplasm Recurrence, LocalPituitary GlandPituitary NeoplasmsYoung Adultimmunohistochemistryintracranial seminomamagnetic resonance imagingsurgery

Identifiers

PMID39311782
PMCPMC11420978

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.